<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02622022</url>
  </required_header>
  <id_info>
    <org_study_id>2015-002533-22</org_study_id>
    <nct_id>NCT02622022</nct_id>
  </id_info>
  <brief_title>Palliation of Dyspnea With Morphine in Patients With Interstitial Lung Disease</brief_title>
  <acronym>MORPHILD</acronym>
  <official_title>Palliation of Dyspnea With Morphine in Patients With Interstitial Lung Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Skanderbog Apotek</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      36 patients with interstitial lung disease will be randomized to 1 weeks treatment with
      morphine hydrochloride as oral linctus 5 mg, four times a day, and 5 mg as needed up to 4
      times a day, or corresponding doses of placebo.

      VAS score for dyspnea will be evaluated after 1 hour and 1 week at follow up. Other
      questionnaires will also be evaluated (GAD-7, K-BUILD, Leicester score)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS dyspnea score</measure>
    <time_frame>1 week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxygen saturation</measure>
    <time_frame>1 hour and 1 week</time_frame>
    <description>Peripheral oxygen saturation will be measured after first dose of morphine and placebo as well as after 1 week follow up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>K-bild questionnaire</measure>
    <time_frame>1 week</time_frame>
    <description>questionnaire regarding interstitial lung specific life quality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GAD-7 questionnaire</measure>
    <time_frame>1 week</time_frame>
    <description>VAlidatet score for anxiety and depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 min walk test</measure>
    <time_frame>1 hour and 1 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Leicester Score</measure>
    <time_frame>1 week</time_frame>
    <description>cough related score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Interstitial Lung Disease</condition>
  <condition>Dyspnea</condition>
  <condition>Morphine</condition>
  <arm_group>
    <arm_group_label>Morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>18 patients treated with oral morphine hydrochloride linctus 5 mg 4 four times daily and as needed up to 4 times daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>18 patients treated with oral linctus corresponding to 5 mg morphine hydrochloride, four times daily and as needed up to 4 times daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine hydrochloride</intervention_name>
    <arm_group_label>Morphine</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A diagnosis of interstitial lung disease (IPF, NSIP, RA-ILS, Scl-ILS, MCTD-ILS,
             asbestous, drug induced ILD, unclassified ILD)

          -  Dyspnea corresponding to Medial Research Councils (MRC) dyspnea score ≥ 3

          -  Written consent

          -  Age ≥ 18 years

          -  Competent

          -  For fertile women: Negative pregnancy test

          -  For fertile and sexually active participants: Use of safe anti-conceptionals

        Exclusion Criteria:

          -  Ongoing infection

          -  Decreased lung function to a degree which makes any form of respiratory depression
             life threatening

          -  Treatment with morphine or morphine analogues

          -  Allergy towards morphine hydrochloride
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>110 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus C</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlotte Andersen, MD Phd</last_name>
      <email>cua@farm.au.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2015</study_first_submitted>
  <study_first_submitted_qc>December 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2015</study_first_posted>
  <last_update_submitted>May 3, 2018</last_update_submitted>
  <last_update_submitted_qc>May 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Aarhus</investigator_affiliation>
    <investigator_full_name>Charlotte Andersen</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>randomised</keyword>
  <keyword>placebo controlled</keyword>
  <keyword>clinical trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Dyspnea</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

